Advertisement
Screener

Siga Technologies INC (SIGA) Shareholders' Equity

2.8 / 5 stars · 68/120 Roast Me

Siga Technologies INC Shareholders' Equity

Siga Technologies INC (SIGA) had Shareholders' Equity of $165.29 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2026-08-06

  • 2026-06-30: Stockholders' Equity Attributable to Parent $165.29M.
  • 2026-03-31: Stockholders' Equity Attributable to Parent $151.62M.
  • 2025-12-31: Stockholders' Equity Attributable to Parent $198.82M.
  • 2025-09-30: Stockholders' Equity Attributable to Parent $203.48M.
Period endStockholders' Equity Attributable to ParentStockholders' Equity Attributable to Parent as first filed
2026-06-30$165.29M
10-Q · filed 2026-08-06
2026-03-31$151.62M
10-Q · filed 2026-08-06
2025-12-31$198.82M
10-Q · filed 2026-08-06
2025-09-30$203.48M
10-Q · filed 2025-11-06
2025-06-30$209.31M
10-Q · filed 2026-08-06
2025-03-31$216.13M
10-Q · filed 2026-08-06
2024-12-31$215.80M
10-Q · filed 2026-08-06
2024-09-30$169.44M
10-Q · filed 2025-11-06
2024-06-30$167.56M
10-Q · filed 2025-11-06
2024-03-31$164.99M
10-Q · filed 2025-08-05
2023-12-31$196.86M
10-K · filed 2026-03-10
2023-09-30$124.14M
10-Q · filed 2024-11-07
2023-06-30$124.07M
10-Q · filed 2024-11-07
2023-03-31$162.09M
10-Q · filed 2024-08-01
2022-12-31$170.16M
10-K · filed 2026-03-10
2022-09-30$173.14M
10-Q · filed 2023-11-07
2022-06-30$139.77M
10-Q · filed 2023-11-07
2022-03-31$167.74M
10-Q · filed 2023-08-08
2021-12-31$174.31M
10-K · filed 2025-03-11
2021-09-30$106.56M
10-Q · filed 2022-11-03
2021-06-30$116.72M
10-Q · filed 2022-11-03
2021-03-31$122.68M
10-Q · filed 2022-08-04
2020-12-31$129.79M
10-K · filed 2024-03-12
2020-09-30$112.96M
10-Q · filed 2021-11-04
2020-06-30$94.13M
10-Q · filed 2021-11-04
2020-03-31$88.14M
10-Q · filed 2021-08-05
2019-12-31$97.78M
10-K · filed 2023-03-02
2019-09-30$102.87M
10-Q · filed 2020-11-05
2019-06-30$103.45M
10-Q · filed 2020-11-05
2019-03-31$106.07M
10-Q · filed 2020-08-06
2018-12-31$102.91M
10-K · filed 2022-03-03
2018-09-30$52.47M
10-Q · filed 2019-11-05
2018-06-30-$341.32M
10-Q · filed 2019-11-05
-$341.32M
10-Q · filed 2018-08-07
2018-03-31-$334.62M
10-Q · filed 2019-08-06
2017-12-31-$323.14M
10-K · filed 2021-03-04
2017-09-30-$312.83M
10-Q · filed 2017-11-07
2017-06-30-$303.41M
10-Q · filed 2017-08-03
2017-03-31-$296.14M
10-Q · filed 2017-05-04
2016-12-31-$287.42M
10-K · filed 2020-03-05
2016-09-30-$313.16M
10-Q · filed 2016-11-02
2016-06-30-$304.07M
10-Q · filed 2016-08-08
2016-03-31-$294.68M
10-Q · filed 2016-05-04
2015-12-31-$284.43M
10-K · filed 2019-03-06
2015-09-30-$264.67M
10-Q · filed 2015-10-27
2015-06-30-$259.39M
10-Q · filed 2015-08-04
2015-03-31-$253.20M
10-Q · filed 2015-05-06
2014-12-31-$246.50M
10-K · filed 2018-03-06
2014-09-30-$227.98M
10-Q · filed 2014-11-04
2014-06-30$11.57M
10-Q · filed 2014-07-31
2014-03-31$13.94M
10-Q · filed 2014-05-01
2013-12-31$16.98M
10-K · filed 2017-03-07
2013-09-30$19.32M
10-Q · filed 2013-11-06
2013-06-30$23.41M
10-Q · filed 2013-08-05
2013-03-31$25.50M
10-Q · filed 2013-05-15
2012-12-31$28.24M
10-K · filed 2016-03-04
$28.95M
10-K · filed 2013-03-06
2012-09-30$30.47M
10-K/A · filed 2013-05-15
$31.74M
10-Q · filed 2012-11-05
2012-06-30$33.09M
10-K/A · filed 2013-05-15
$34.25M
10-Q · filed 2012-08-06
2012-03-31$36.47M
10-K/A · filed 2013-05-15
$37.95M
10-Q · filed 2012-05-07
2011-12-31$40.77M
10-K · filed 2015-03-06
$41.69M
10-K · filed 2012-03-01
2011-09-30$44.37M
10-K/A · filed 2013-05-15
$45.98M
10-Q · filed 2011-11-08
2011-06-30$33.22M
10-K/A · filed 2013-05-15
$42.95M
10-Q · filed 2011-08-01
2011-03-31-$2.13M
10-K/A · filed 2013-05-15
2010-12-31-$12.91M
10-K/A · filed 2013-05-15
$12.07M
10-Q · filed 2011-08-01
2009-12-31-$12.91M
10-K · filed 2014-03-10
$7.15M
10-K · filed 2012-03-01
2008-12-31$1.36K
10-K · filed 2012-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B